Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Acutus Medical’s $77 Million Shares Offering
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. executed its SEC-registered public offering of 5,500,000 shares of common stock for an aggregate price...
SmartFit’s R$2.3 Billion Initial Public Offering
Simpson & Thacher and Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga advised SmartFit Escola de Ginástica e Dança S.A on the deal, while Davis Polk...
Sight Sciences’ $240 Million Initial Public Offering
Latham & Watkins LLP represented Sight Sciences, Inc. in the offering, while Davis Polk advised the representatives of the several underwriters. Sight Sciences, Inc. executed its initial public...
Black Spade Acquisition Co’s $169 Million SPAC IPO
Appleby acted as Cayman counsel to Black Spade Acquisition Co on its SPAC IPO on The New York Stock Exchange. Davis Polk also advised Black Spade...
Membership Collective Group’s US$420 Million IPO
Sidley Austin LLP advised Membership Collective Group Inc. on the deal, while Davis Polk advised the underwriters. Membership Collective Group (“MCG”), a global membership platform comprised...
Tencent Holdings Limited’s GBP919 Million Recommended Cash Acquisition of Sumo Group plc
Allen & Overy advised Sumo Group plc on the deal, while Davis Polk advised Tencent Holdings Limited. Tencent Holdings Limited made an all cash acquisition through its indirect...
Kindstar Globalgene Technology’s US$285.2 Million IPO
S&C acted as Hong Kong and U.S. counsel to the joint sponsors and underwriters, including Goldman Sachs, CICC and Credit Suisse. Davis Polk advised Kindstar Globalgene...
IDEAYA Biosciences’ $92 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
Salesforce.com’s $8 Billion Debt Offering
Davis Polk advised the joint book-running managers in the offering. Salesforce.com, Inc. executed its offering consisting of $1 billion of its 0.625% notes due 2024, $1 billion...
Mizuho Financial Group’s $1.75 Billion Senior Notes Offering
Davis Polk advised the joint bookrunners and lead managers in the offering. Mizuho Financial Group, Inc. completed its SEC-registered takedown offering of senior notes, which consisted of...
Novo Nordisk’s Acquisition of Neotope Neuroscience
Davis Polk, working alongside Matheson, advised Novo Nordisk on the deal. Novo Nordisk A/S completed its acquisition of Neotope Neuroscience Limited from Prothena Biosciences Limited for...